Next Article in Journal
The Biological Role of PI3K Pathway in Lung Cancer
Previous Article in Journal
Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges
Previous Article in Special Issue
Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2012, 5(11), 1210-1235;

The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance

Novartis Institute for Tropical Diseases Pte Ltd, 10 Biopolis Road #05-01, Chromos, 138670, Singapore
Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Clinical Research Centre, 10 Medical Drive, 117597, Singapore
Current address: Public Health Research Institute, 225 Warren St, Newark, NJ 07103, USA.
Author to whom correspondence should be addressed.
Received: 27 August 2012 / Revised: 25 October 2012 / Accepted: 2 November 2012 / Published: 9 November 2012
(This article belongs to the Special Issue Antituberculosis Drugs)
Full-Text   |   PDF [517 KB, uploaded 9 November 2012]   |  


In the fight against tuberculosis, cell wall permeation of chemotherapeutic agents remains a critical but largely unsolved question. Here we review the major mechanisms of small molecule penetration into and efflux from Mycobacterium tuberculosis and other mycobacteria, and outline how these mechanisms may contribute to the development of phenotypic drug tolerance and induction of drug resistance. M. tuberculosis is intrinsically recalcitrant to small molecule permeation thanks to its thick lipid-rich cell wall. Passive diffusion appears to account for only a fraction of total drug permeation. As in other bacterial species, influx of hydrophilic compounds is facilitated by water-filled open channels, or porins, spanning the cell wall. However, the diversity and density of M. tuberculosis porins appears lower than in enterobacteria. Besides, physiological adaptations brought about by unfavorable conditions are thought to reduce the efficacy of porins. While intracellular accumulation of selected drug classes supports the existence of hypothesized active drug influx transporters, efflux pumps contribute to the drug resistant phenotype through their natural abundance and diversity, as well as their highly inducible expression. Modulation of efflux transporter expression has been observed in phagocytosed, non-replicating persistent and multi-drug resistant bacilli. Altogether, M. tuberculosis has evolved both intrinsic properties and acquired mechanisms to increase its level of tolerance towards xenobiotic substances, by preventing or minimizing their entry. Understanding these adaptation mechanisms is critical to counteract the natural mechanisms of defense against toxic compounds and develop new classes of chemotherapeutic agents that positively exploit the influx and efflux pathways of mycobacteria. View Full-Text
Keywords: Mycobacterium tuberculosis; drug transport; efflux; porins; resistance; persistence Mycobacterium tuberculosis; drug transport; efflux; porins; resistance; persistence

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Sarathy, J.P.; Dartois, V.; Lee, E.J.D. The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance. Pharmaceuticals 2012, 5, 1210-1235.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top